The leading Indian drugmaker Ranbaxy Laboratories Ltd. said on Tuesday it has submitted a bid for the generics unit of Germany’s Merck KGaA.
The buy-out of the unit could be worth as much as 5 billion Euros (US $6.58 billion), analysts...
Indian drug giant Ranbaxy makes bid for the generic drugs unit of Merck KGaA in Germany
Made Popular Mar 14 2007
The leading Indian drugmaker Ranbaxy Laboratories Ltd. said on Tuesday it has submitted a bid for the generics unit of Germany’s Merck KGaA.
The buy-out of the unit could be worth as much as 5 billion Euros (US $6.58 billion), analysts...
Add your Comment
Home

Delicious
Digg
Facebook
Reddit
Stumble Upon
Technorati
Mixx
Sphinn
Twitter
SphereIt
Propeller
Gmarks
Newsvine
Yahoo! My Web
Live Journal
Blinklist
E-mail




